undamentalytics Newsletter

Ping An Biomedical Co. vs Xcel Brands

Ping An Biomedical Co. and Xcel Brands are similar in size: $4.7m and $4.9m of revenue in their latest fiscal years. Xcel Brands grew faster (-40.2% against -61.1%). Ping An Biomedical Co. kept more of each dollar of sales as profit: a net margin of -37.6% against -353.5%.

Latest fiscal yearPing An Biomedical Co.PASW, 2025Xcel BrandsXELB, 2025
Revenue $4.7m $4.9m
Revenue growth -61.1% -40.2%
Net income −$1.8m −$17.5m
Operating margin -43.1% —
Net margin -37.6% -353.5%
Return on equity -66.7% -72.2%
Free cash flow — −$7.0m
Cash $164,697 $1.1m
Total debt $1.4m $13.6m
Debt to equity 22.1% —
Dividend per share — —
Dividend yield — —
Share buybacks — $204,000
Employees — 15
Market value $87.3m $2.5m
Price vs our value range — —
Moat score — 48 (Moderate)
Insider trades, 12 months 0 buys, 0 sales 8 buys, 0 sales

Each figure is from the company's latest annual report and links to the page it comes from. Fiscal years can end on different dates. Market value and the value verdict use the delayed price shown on the stock pages. Not a recommendation.

Go deeper

Figures from each company's latest annual report filed with the SEC (10-K or 20-F), as reported, with the fiscal year shown. Not investment advice. How we read filings: methodology.